These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28736363)

  • 1. [Clinical characteristics and risk factors affecting outcomes of elderly patients with non-small cell lung cancer complicated by chronic obstructive pulmonary disease].
    Wang P; Zhang D; Guo XG; Sun BJ; Fang XQ; Qu GP; Liu CT
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jul; 37(7):889-894. PubMed ID: 28736363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between chronic obstructive pulmonary disease and non-small cell lung cancer in the elderly.
    Wang P; Zhu M; Zhang D; Guo XG; Zhao S; Zhang XL; Wang DL; Liu CT
    Cancer Med; 2019 Aug; 8(9):4124-4134. PubMed ID: 31184445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.
    Lim JU; Yeo CD; Rhee CK; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():929-938. PubMed ID: 31118602
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
    [No Abstract]   [Full Text] [Related]  

  • 5. [Impact of Chronic Obstructive Pulmonary Disease on Risk of Recurrence in Patients with Resected Non-small Cell Lung Cancer].
    Qiang G; Yu Q; Liang C; Song Z; Shi B; Guo Y; Liu D
    Zhongguo Fei Ai Za Zhi; 2018 Mar; 21(3):215-220. PubMed ID: 29587946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer.
    Lee SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Han SK; Kim YW
    J Thorac Oncol; 2014 Jun; 9(6):812-7. PubMed ID: 24807154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of elderly patients with COPD and newly diagnosed lung cancer, and factors associated with treatment decision.
    Qin J; Li G; Zhou J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1515-20. PubMed ID: 27445471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of comorbidities on long-term outcomes after thoracoscopic surgery for stage I non-small cell lung cancer patients with chronic obstructive pulmonary disease.
    Shibazaki T; Odaka M; Noda Y; Tsukamoto Y; Mori S; Asano H; Yamashita M; Morikawa T
    J Thorac Dis; 2018 Feb; 10(2):909-919. PubMed ID: 29607164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of chronic obstructive pulmonary disease on postoperative recurrence in patients with resected non-small-cell lung cancer.
    Qiang G; Liang C; Xiao F; Yu Q; Wen H; Song Z; Tian Y; Shi B; Guo Y; Liu D
    Int J Chron Obstruct Pulmon Dis; 2016; 11():43-9. PubMed ID: 26766906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Exploration of the treatment model for patients with advanced non-small cell lung cancer complicated with chronic obstructive pulmonary disease based on real-world data].
    Wang F; Xie XH; Lin XQ; Qin YY; Xie ZH; Zhang JX; Ouyang M; Zhou CZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 May; 43(5):450-454. PubMed ID: 32450634
    [No Abstract]   [Full Text] [Related]  

  • 12. Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients.
    Lim JU; Yeo CD; Rhee CK; Kim YH; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2139-2146. PubMed ID: 30034229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
    Iwasaki A; Shirakusa T; Enatsu S; Maekawa S; Yoshida Y; Yoshinaga Y
    Thorac Cardiovasc Surg; 2005 Jun; 53(3):162-7. PubMed ID: 15926096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer.
    Jo H; Park S; Kim NE; Park SY; Ryu YJ; Chang JH; Lee JH
    J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic obstructive pulmonary disease and comorbidities' influence on mortality in non-small cell lung cancer patients.
    Media AS; Persson M; Tajhizi N; Weinreich UM
    Acta Oncol; 2019 Aug; 58(8):1102-1106. PubMed ID: 31092081
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy.
    Omote N; Hashimoto N; Morise M; Sakamoto K; Miyazaki S; Ando A; Nakahara Y; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3541-3547. PubMed ID: 29270008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease.
    Kornmann O; Beeh KM; Beier J; Geis UP; Ksoll M; Buhl R;
    Respiration; 2003; 70(1):67-75. PubMed ID: 12584394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease.
    Shin SH; Park HY; Im Y; Jung HA; Sun JM; Ahn JS; Ahn MJ; Park K; Lee HY; Lee SH
    Int J Cancer; 2019 Nov; 145(9):2433-2439. PubMed ID: 30807641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort.
    Sawa K; Koh Y; Kawaguchi T; Kambayashi S; Asai K; Mitsuoka S; Kimura T; Yoshimura N; Yoshimoto N; Kubo A; Saka H; Matsumura A; Wanibuchi H; Yamamoto N; Nishiyama N; Hirata K
    Lung Cancer; 2017 Oct; 112():96-101. PubMed ID: 29191607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
    Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.